INTEGRATED BIOPHARMA INC (INBP) › Capital ExpendituresINTEGRATED BIOPHARMA INC (INBP) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2011: $301.0K2012: $155.0K2013: $30.0K2014: $182.0K2015: $235.0K2016: $109.0K2017: $327.0K2018: $247.0K2019: $414.0K2020: $214.0K2021: $295.0K2022: $486.0K2023: $116.0K2024: $553.0K2025: $191.0K$191.0K2011Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$191.0K-65.5%2024$553.0K+376.7%2023$116.0K-76.1%2022$486.0K+64.7%2021$295.0K+37.9%2020$214.0K-48.3%2019$414.0K+67.6%2018$247.0K-24.5%2017$327.0K+200.0%2016$109.0K-53.6%2015$235.0K+29.1%2014$182.0K+506.7%2013$30.0K-80.6%2012$155.0K-48.5%2011$301.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share